In accordance with this observation, we detected no difference in circulating tumor markers Chromogranin A or 5-hydroxyindoleacetic acid (5-HIAA) urine secretion, possible biomarkers for CHD [23], between patients with myocardial metastases compared to the overall registry. The gene discussed is CHGA; the disease is neoplasm.